Through univariate and multivariate examinations, elevated SF3A2 emerged as an autonomous risk indicator for CRC patients regarding OS (Table 1) and DSS (Table 2), rather than PFI (Table 3). The gene discussed is SF3A2; the disease is colorectal carcinoma.